Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors



Status:Active, not recruiting
Conditions:Hospital, Lymphoma
Therapuetic Areas:Oncology, Other
Healthy:No
Age Range:18 - Any
Updated:5/20/2018
Start Date:April 2014
End Date:April 2019

Use our guide to learn which trials are right for you!

This study will test whether cardiac MRI can improve early detection of Hodgkin lymphoma
associated heart disease compared to a stress echocardiogram. By doing both stress
echocardiography and cardiac MRI, we will compare the ability of the two tests to detect
heart disease.


Inclusion Criteria:

- Classical or nodular lymphocyte predominant HL treated at Memorial Sloan-Kettering
Cancer Center.

- Age ≥ 18 years

- Treatment for HL that included mediastinal RT at initial diagnosis or relapse.

- ≥ 5 years from last HL treatment.

Exclusion Criteria:

- Primary HL diagnosis prior to 1980.

- Additional mediastinal RT or subsequent cardiotoxic systemic therapy for secondary
malignant neoplasm.

- Known CAD/CHF (defined as documented myocardial infarction, cardiac revascularization,
angiographic obstructive CAD, or decreased LV function [EF < 55%] during prior
clinical care).

- Contraindication to MRI (i.e. pacemakers, defibrillators, or aneurysm clips, or other
implanted ferromagnetic objects), gadolinium (i.e. known hypersensitivity to
gadolinium, advanced renal insufficiency as defined by glomerular filtration rate <30
ml/min/1.73m^2).

- Contraindication to exercise stress testing other than the above (i.e. unstable angina
or severe valvular stenosis).
We found this trial at
1
site
1275 York Ave
New York, New York 10021
(212) 639-2000
Principal Investigator: Matthew Matasar, MD
Phone: 212-639-8889
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials